Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
glucagon (1 trial)
ly900018 (4 trials)
oxymetazoline (ocuclear) (1 trial)
Common Cold (Phase 1)
Diabetes Mellitus (Phase 1)
Diabetes Mellitus, Type 1 (Phase 1)
Diabetes Mellitus, Type 2 (Phase 1)
Trials (4 total)
Trial APIs (3 total)